Tapentadol is partially metabolized through the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medications that greatly enhance or repress the action/expression of one or more of these enzymes, together with with substrates of these enzymes (due to Competitiveness for that enzyme); some enzyme mediators/substrates involve https://abigailq999qiy0.tusblogos.com/profile